 |
Endeavor BioMedicines
Last updated: August 02, 2024
Co-founder and CEO John Hood
USA | Funding: $295.5M (+)
Website: https://www.endeavorbiomedicines.com/
Endeavor is a clinical-stage company developing a best-in-class Hedgehog inhibitor for Idiopathic Pulmonary Fibrosis.
Website: https://www.endeavorbiomedicines.com/
Endeavor is a clinical-stage company developing a best-in-class Hedgehog inhibitor for Idiopathic Pulmonary Fibrosis.
